tirzepatide heart racing Exacerbation of Postural Orthostatic Tachycardia Syndrome With Prescribed for Weight Loss Compounded Tirzepatide for Women |

Most patients report meaningful appetite suppression between two to four weeks of starting treatment, though individual timing varies based on genetics, dose escalation, and metabolic factors

While managing both ADHD and digestive symptoms presents challenges, understanding these connections empowers patients to develop effective strategies for symptom management

No, GLP-1s Are Not Miracle Weight-Loss Drugs Never trust a frenzy + Some tips for staying grounded when so many media outlets are praising GLP-1s

Keywords: glucagon-like peptide 1 receptor agonists, semaglutide, salivary glands, xerostomia, cyclic AMP, beta-arrestins Abstract This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used for diabetes and obesity